April 9th 2013EP. 1: Episode 1 - The Prevalence of Comorbid Cardiometabolic Disorders in the US
April 9th 2013EP. 2: Episode 3 - The Diversity of Patient Populations
April 9th 2013EP. 3: Episode 2 - The Challenges of Disease Management: Clinician and Provider Perspectives
April 9th 2013EP. 4: Episode 4 - The Link Between Diabetes and Cardiovascular Disease
April 9th 2013EP. 5: Episode 5 - Setting the Tone: Current Therapeutic Goals
April 9th 2013EP. 6: Episode 6 - Diabetes and the Burden of Disease
April 9th 2013EP. 7: Episode 7 - The Complex Equation of Management
April 9th 2013EP. 8: Episode 8 - A Diverse Patient Population and Its Challenges
April 9th 2013EP. 9: Episode 9 - Current Challenges and Gaps in Patient Care
April 9th 2013EP. 10: Episode 10 - Drivers of Cost in Cardiometabolic Management
April 9th 2013EP. 11: Episode 11- Future Outlook on Preventive Care
April 9th 2013EP. 12: Episode 12- Comparing Current Healthcare Spending to Patient Outcomes
April 9th 2013EP. 13: Episode 13- Current Developments of Pharmacotherapeutic Spending
April 9th 2013EP. 14: Episode 14- Recent Trends in the Epidemiology of Cardiometabolic Conditions
April 9th 2013EP. 15: Episode 15- Assessing the Factors at Increased Risk for Cardiometabolic Events
April 9th 2013EP. 16: Episode 16- Exploring the Benefits and Limitations of Available Agents
April 9th 2013EP. 17: Episode 17 - Evolving Guidelines for the Treatment of Cardiometabolic Events
April 9th 2013EP. 18: Episode 18 - Impact of Obesity on Cardiometabolic Events
April 9th 2013EP. 19: Episode 19 - - Initiatives Aim to Control Cardiometabolic Events
April 9th 2013EP. 20: Episode 20 - Pharmacotherapeutic Initiatives
April 9th 2013EP. 21: Episode 21 - Expectations for Newly Developing Agents
April 9th 2013EP. 22: Episode 22 - Antiplatelet Agents Explored
April 9th 2013EP. 23: Episode 23 - The Affordable Care Act and Healthcare Reform
April 9th 2013EP. 24: Episode 24 - Accountable Care Organizations
April 9th 2013EP. 25: Episode 25 - Closing Remarks
